🚨Exciting news from the intranasal Covid vaccine front!🚨 Participants who received a single dose of CVXGA 👃had a 78% lower risk of developing symptomatic COVID-19 infection compared to the placebo group in the first month after vaccine administration 
 #MedSky

www.businesswire.com/news/home/20...